Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Steven Pieper

See Remarks at Xeris Biopharma Holdings, Inc. (XERS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $515K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC XERSXeris Biopharma Holdings, Inc. Sell Plan 5,0001,351,053 held (−0%) $9.41 $47K +11.4%
Sep 1SEC XERSXeris Biopharma Holdings, Inc. Sell Plan 5,0001,356,053 held (−0%) $8.50 $42K +23.3%
Aug 12SEC XERSXeris Biopharma Holdings, Inc. Sell Plan 5,0001,361,053 held (−0%) $8.50 $42K +23.3%
Jul 7SEC XERSXeris Biopharma Holdings, Inc. Sell Plan 17,4001,393,653 held (−1%) $8.50 $148K +23.3%
Jul 7SEC XERSXeris Biopharma Holdings, Inc. Sell Plan 27,6001,366,053 held (−2%) $8.52 $235K +23.0%
  • Sell

    See Remarks Steven Pieper sold $47K of XERS at $9.41 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Steven Pieper sold $42K of XERS at $8.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Steven Pieper sold $42K of XERS at $8.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Steven Pieper sold $148K of XERS at $8.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Steven Pieper sold $235K of XERS at $8.52 — pre-scheduled 10b5-1 plan sale.